|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions affects response to substance increases phosphorylation |
EXP |
ABL1 protein affects the reaction [Potassium Chloride results in increased phosphorylation of BCAR1 protein] ABL1 protein affects the susceptibility to Potassium Chloride Potassium Chloride results in increased phosphorylation of ABL1 protein |
CTD |
PMID:17615370 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
EXP |
molybdate inhibits the reaction [Potassium Chloride inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]]; Potassium Chloride inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] |
CTD |
PMID:3015922 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Anxa1 |
annexin A1 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of ANXA1 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of APOE mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Aqp1 |
aquaporin 1 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of AQP1 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of ARID3A mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of ARID5B mRNA |
CTD |
PMID:29691375 |
|
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
multiple interactions |
ISO |
Potassium Chloride inhibits the reaction [ATP1A3 protein binds to Ouabain] |
CTD |
PMID:24631656 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
multiple interactions increases phosphorylation |
EXP |
ABL1 protein affects the reaction [Potassium Chloride results in increased phosphorylation of BCAR1 protein] |
CTD |
PMID:17615370 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of BCL2L10 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:76,107,326...76,113,373
Ensembl chr 8:76,107,326...76,113,367
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions increases expression decreases methylation |
ISO |
BDNF promoter modified form affects the reaction [Potassium Chloride results in increased expression of BDNF mRNA]; Potassium Chloride inhibits the reaction [HDAC1 protein binds to BDNF promoter]; Potassium Chloride inhibits the reaction [MECP2 protein binds to BDNF promoter]; Potassium Chloride inhibits the reaction [SIN3A protein binds to BDNF promoter]; Potassium Chloride promotes the reaction [CREB1 protein binds to BDNF promoter] Potassium Chloride results in decreased methylation of BDNF promoter |
CTD |
PMID:14593183 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of BTG2 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C13h1orf74 |
similar to human chromosome 1 open reading frame 74 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of C1ORF74 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr13:104,692,769...104,695,368
Ensembl chr13:104,692,824...104,695,470
|
|
G |
C6h14orf28 |
similar to human chromosome 14 open reading frame 28 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of C14ORF28 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 6:82,965,304...82,973,942
Ensembl chr 6:82,965,328...82,972,558
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
ISO EXP |
[omega-Agatoxin IVA results in decreased activity of CACNA1A protein] which results in decreased susceptibility to Potassium Chloride; gabapentin promotes the reaction [[omega-Agatoxin IVA results in decreased activity of CACNA1A protein] which results in decreased susceptibility to Potassium Chloride] CACNA1A protein affects the reaction [Potassium Chloride results in increased abundance of Nitric Oxide] |
CTD |
PMID:12770949 PMID:12817894 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
multiple interactions |
EXP |
CACNA1B protein affects the reaction [Potassium Chloride results in increased abundance of Nitric Oxide] |
CTD |
PMID:12770949 |
|
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
multiple interactions |
ISO |
[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein; Nifedipine inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]; Peroxynitrous Acid inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:20128810 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
multiple interactions |
ISO |
[gabapentin binds to and results in decreased activity of CACNA2D1 protein] which results in decreased susceptibility to Potassium Chloride; [gabapentin results in decreased activity of CACNA2D1 protein] inhibits the reaction [Potassium Chloride results in increased transport of Calcium]; CACNA2D1 protein affects the reaction [Potassium Chloride results in increased transport of Calcium] |
CTD |
PMID:17442347 PMID:17881535 |
|
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions increases expression increases secretion |
EXP |
Carbon Dioxide inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Fentanyl inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]]; Naloxone inhibits the reaction [Fentanyl inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]]; Nefopam inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; nociceptin (1-13) amide inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Plant Extracts inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Polyphenols inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Topiramate inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein] Potassium Chloride results in increased expression of CALCA mRNA |
CTD |
PMID:12574409 PMID:14991081 PMID:16942474 PMID:17640294 PMID:17997062 PMID:18052948 PMID:19096234 PMID:27030709 More...
|
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
multiple interactions |
EXP |
CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of MAPK3 protein]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of SRC protein] |
CTD |
PMID:18004999 |
|
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of CAT mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride] |
CTD |
PMID:18178722 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cav3 |
caveolin 3 |
multiple interactions |
ISO |
CAV3 protein affects the reaction [Potassium Chloride results in increased uptake of Calcium] |
CTD |
PMID:21294223 |
|
NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137
|
|
G |
Cavin4 |
caveolae associated protein 4 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of MURC mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:62,996,906...63,007,677
Ensembl chr 5:62,996,865...63,007,678
|
|
G |
Ccdc71 |
coiled-coil domain containing 71 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of CCDC71 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:109,146,650...109,161,749
Ensembl chr 8:109,146,359...109,165,216
|
|
G |
Chrna10 |
cholinergic receptor nicotinic alpha 10 subunit |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of CHRNA10 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:156,487,279...156,494,277
Ensembl chr 1:156,487,279...156,491,476
|
|
G |
Cirbp |
cold inducible RNA binding protein |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of CIRBP mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cln8 |
CLN8, transmembrane ER and ERGIC protein |
multiple interactions |
ISO |
CLN8 protein affects the reaction [[Potassium Chloride co-treated with Calcium] results in increased transport of D-Aspartic Acid] |
CTD |
PMID:22302580 |
|
NCBI chr16:74,749,662...74,759,553
Ensembl chr16:74,749,662...74,759,774
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
multiple interactions decreases expression |
EXP |
[(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone binds to and results in increased activity of CNR1 protein] affects the reaction [Potassium Chloride results in increased transport of Calcium]; [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] affects the reaction [Potassium Chloride results in increased transport of Calcium]; Calcium affects the reaction [Potassium Chloride results in decreased expression of CNR1 mRNA]; Calcium affects the reaction [Potassium Chloride results in decreased expression of CNR1 protein]; CNR1 protein affects the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Potassium Chloride results in increased transport of Calcium]]; CNR1 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [Potassium Chloride results in increased transport of Calcium]]; Rimonabant inhibits the reaction [[(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone binds to and results in increased activity of CNR1 protein] inhibits the reaction [Potassium Chloride results in increased transport of Calcium]]; Rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [Potassium Chloride results in increased transport of Calcium]] Potassium Chloride results in decreased expression of CNR1 mRNA; Potassium Chloride results in decreased expression of CNR1 protein |
CTD |
PMID:12421626 PMID:16412482 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation |
EXP ISO |
1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of CREB1 protein]; AG 1879 inhibits the reaction [Potassium Chloride results in increased phosphorylation of CREB1 protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of CREB1 protein]; SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of CREB1 protein] [Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein; Nifedipine inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]; Peroxynitrous Acid inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein] Nifedipine inhibits the reaction [Potassium Chloride results in increased phosphorylation of CREB1 protein]; Peroxynitrous Acid inhibits the reaction [Potassium Chloride results in increased phosphorylation of CREB1 protein]; Potassium Chloride promotes the reaction [CREB1 protein binds to BDNF promoter] |
CTD |
PMID:14593183 PMID:18004999 PMID:20128810 PMID:20211981 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
increases expression multiple interactions |
ISO |
Potassium Chloride results in increased expression of CYP11B1 mRNA benidipine inhibits the reaction [Potassium Chloride results in increased expression of CYP11B1 mRNA] |
CTD |
PMID:18331727 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions increases expression |
ISO |
benidipine inhibits the reaction [Potassium Chloride results in increased expression of CYP11B2 mRNA] |
CTD |
PMID:18331727 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression multiple interactions |
EXP |
Potassium Chloride results in increased expression of DUSP1 mRNA Calcium affects the reaction [Potassium Chloride results in increased expression of DUSP1 mRNA] |
CTD |
PMID:11577072 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased expression of EDN1 mRNA; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein] |
CTD |
PMID:18823320 PMID:21811393 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
ISO |
[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] affects the activity of EDNRA protein |
CTD |
PMID:18516094 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA; Atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA] |
CTD |
PMID:18823320 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions |
EXP |
[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein] |
CTD |
PMID:21811393 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fam53c |
family with sequence similarity 53, member C |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of FAM53C mRNA |
CTD |
PMID:29691375 |
|
NCBI chr18:26,364,050...26,378,173
Ensembl chr18:26,364,039...26,376,775
|
|
G |
Fastkd5 |
FAST kinase domains 5 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of FASTKD5 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 3:117,830,219...117,847,707
Ensembl chr 3:117,830,083...117,847,820
|
|
G |
Fbxo33 |
F-box protein 33 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of FBXO33 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
|
|
G |
Fermt3 |
FERM domain containing kindlin 3 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of FERMT3 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:204,189,483...204,207,683
Ensembl chr 1:204,189,484...204,207,587
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
EXP |
Potassium Chloride results in increased expression of FGF1 protein |
CTD |
PMID:15264218 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions affects localization |
EXP |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Potassium Chloride affects the localization of FMR1 protein]; methyl-(4-carboxyphenyl)glycine inhibits the reaction [Potassium Chloride affects the localization of FMR1 protein] Potassium Chloride affects the localization of FMR1 mRNA; Potassium Chloride affects the localization of FMR1 protein |
CTD |
PMID:15028757 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions affects expression |
EXP |
[Nifedipine co-treated with omega-Conotoxin GVIA co-treated with omega-Agatoxin IVA] inhibits the reaction [Potassium Chloride affects the expression of FOS mRNA]; naphthol AS-E phosphate inhibits the reaction [Potassium Chloride affects the expression of FOS mRNA] |
CTD |
PMID:20211981 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Potassium Chloride results in increased expression of FOSB mRNA Dronabinol inhibits the reaction [Potassium Chloride results in increased expression of FOSB mRNA] |
CTD |
PMID:29691375 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of FXYD2 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
|
|
G |
Gap43 |
growth associated protein 43 |
multiple interactions increases expression |
EXP |
1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; KN 62 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; PLD2 protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 protein] Potassium Chloride results in increased expression of GAP43 mRNA; Potassium Chloride results in increased expression of GAP43 protein |
CTD |
PMID:18004999 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gata3 |
GATA binding protein 3 |
increases expression |
EXP |
Potassium Chloride results in increased expression of GATA3 mRNA |
CTD |
PMID:21624428 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gcg |
glucagon |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GCG mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GCLC mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
Potassium Chloride results in increased expression of GFAP protein |
CTD |
PMID:27422357 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GLP1R mRNA |
CTD |
PMID:22228705 |
|
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions |
EXP |
GNAS protein affects the susceptibility to [Potassium Chloride co-treated with Isoproterenol] |
CTD |
PMID:10696522 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
increases abundance multiple interactions |
EXP |
Potassium Chloride results in increased abundance of GNRH1 protein Methoxychlor promotes the reaction [Potassium Chloride results in increased abundance of GNRH1 protein] |
CTD |
PMID:3097876 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2 |
multiple interactions |
ISO |
[Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:10464266 |
|
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
|
|
G |
Gpr75 |
G protein-coupled receptor 75 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of GPR75 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr14:104,609,542...104,618,885
Ensembl chr14:104,611,089...104,620,370
|
|
G |
Grin2d |
glutamate ionotropic receptor NMDA type subunit 2D |
decreases expression |
ISO |
Potassium Chloride results in decreased expression of GRIN2D protein |
CTD |
PMID:19911010 |
|
NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTA5 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTT1 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTT2 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
Potassium Chloride inhibits the reaction [HDAC1 protein binds to BDNF promoter] |
CTD |
PMID:14593183 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions increases phosphorylation |
ISO |
KN 93 inhibits the reaction [Potassium Chloride results in increased phosphorylation of HDAC5 protein] |
CTD |
PMID:17988634 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression |
EXP |
Potassium Chloride affects the expression of HMOX1 mRNA |
CTD |
PMID:22954530 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hps6 |
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of HPS6 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:244,853,256...244,855,865
Ensembl chr 1:244,853,194...244,855,883
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Potassium Chloride affects the reaction [diethyl phthalate affects the expression of ICAM1 protein]; Potassium Chloride affects the reaction [Dinitrochlorobenzene affects the expression of ICAM1 protein]; Potassium Chloride affects the reaction [Lipopolysaccharides affects the expression of ICAM1 protein]; Potassium Chloride affects the reaction [Salicylic Acid affects the expression of ICAM1 protein] |
CTD |
PMID:30842373 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ift70b |
intraflagellar transport 70B |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of IFT70B mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 3:60,855,809...60,858,380
Ensembl chr 3:60,855,575...60,858,389
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases response to substance multiple interactions |
EXP |
IGF1 protein results in increased susceptibility to Potassium Chloride [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of IGF1 mRNA |
CTD |
PMID:11159833 PMID:22228705 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
affects response to substance |
EXP |
IGFBP4 protein affects the susceptibility to Potassium Chloride |
CTD |
PMID:11159833 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Il10 |
interleukin 10 |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of IL10 protein |
CTD |
PMID:27422357 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions affects response to substance |
EXP ISO |
Halothane affects the reaction [IL1B protein affects the susceptibility to Potassium Chloride] Potassium Chloride inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein]; Potassium Chloride inhibits the reaction [titanium dioxide results in increased secretion of IL1B protein] |
CTD |
PMID:11506125 PMID:18403674 PMID:30320338 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Inhbb |
inhibin subunit beta B |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of INHBB mRNA |
CTD |
PMID:29691375 |
|
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Ins1 |
insulin 1 |
increases secretion multiple interactions |
EXP ISO |
Potassium Chloride results in increased secretion of INS1 protein Dexamethasone inhibits the reaction [Potassium Chloride results in increased secretion of INS1 protein]; SLC30A8 protein affects the reaction [Potassium Chloride results in increased secretion of INS1 protein] [Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; arsenite inhibits the reaction [Potassium Chloride results in increased secretion of INS1 protein]; dimethylarsinous acid inhibits the reaction [Potassium Chloride results in increased secretion of INS1 protein]; methylarsonite inhibits the reaction [Potassium Chloride results in increased secretion of INS1 protein]; Potassium Chloride inhibits the reaction [FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Potassium Chloride promotes the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:10464266 PMID:19479076 PMID:23236509 PMID:23530660 PMID:29161229 PMID:31332465 PMID:31778773 PMID:37217659 More...
|
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
sodium arsenite promotes the reaction [Potassium Chloride results in increased secretion of INS protein] |
CTD |
PMID:20100676 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Itm2b |
integral membrane protein 2B |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of ITM2B mRNA |
CTD |
PMID:22228705 |
|
NCBI chr15:48,545,998...48,568,904
Ensembl chr15:48,546,001...48,568,917
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
increases expression |
EXP |
Potassium Chloride results in increased expression of ITPR1 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of JMJD6 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Jrkl |
JRK-like |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of JRKL mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:10,224,172...10,227,068
Ensembl chr 8:10,224,172...10,227,068
|
|
G |
Kcna1 |
potassium voltage-gated channel subfamily A member 1 |
multiple interactions increases expression |
EXP |
[Nifedipine co-treated with omega-Conotoxin GVIA co-treated with omega-Agatoxin IVA] promotes the reaction [Potassium Chloride results in increased expression of KCNA1 mRNA]; naphthol AS-E phosphate promotes the reaction [Potassium Chloride results in increased expression of KCNA1 mRNA] |
CTD |
PMID:20211981 |
|
NCBI chr 4:159,464,223...159,472,905
Ensembl chr 4:159,464,188...159,472,682
|
|
G |
Kcna4 |
potassium voltage-gated channel subfamily A member 4 |
increases expression |
EXP |
Potassium Chloride results in increased expression of KCNA4 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 3:93,756,399...93,778,004
Ensembl chr 3:93,756,446...93,769,162
|
|
G |
Kcnc1 |
potassium voltage-gated channel subfamily C member 1 |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of KCNC1 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 1:96,902,953...96,944,744
Ensembl chr 1:96,902,953...96,944,744
|
|
G |
Kcnc3 |
potassium voltage-gated channel subfamily C member 3 |
increases expression multiple interactions |
EXP |
Potassium Chloride results in increased expression of KCNC3 mRNA [Nifedipine co-treated with omega-Conotoxin GVIA co-treated with omega-Agatoxin IVA] inhibits the reaction [Potassium Chloride results in increased expression of KCNC3 mRNA]; naphthol AS-E phosphate inhibits the reaction [Potassium Chloride results in increased expression of KCNC3 mRNA] |
CTD |
PMID:20211981 |
|
NCBI chr 1:95,080,960...95,095,165
Ensembl chr 1:95,080,960...95,095,160
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
increases expression |
EXP |
Potassium Chloride results in increased expression of KCND2 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of KCNJ1 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
|
|
G |
Klhl15 |
kelch-like family member 15 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of KLHL15 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr X:58,994,726...59,050,207
Ensembl chr X:58,995,461...59,046,069
|
|
G |
Klk8 |
kallikrein related-peptidase 8 |
increases activity |
ISO |
Potassium Chloride results in increased activity of KLK8 protein |
CTD |
PMID:16800733 |
|
NCBI chr 1:94,251,803...94,258,646
Ensembl chr 1:94,251,803...94,258,646
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of KMT2A mRNA |
CTD |
PMID:20211609 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions |
EXP |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; 2-aminoethyl diphenylborinate promotes the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone]; icatibant inhibits the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of Dinoprostone]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein] |
CTD |
PMID:16696851 PMID:21811393 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lats2 |
large tumor suppressor kinase 2 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of LATS2 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr15:31,825,068...31,877,193
Ensembl chr15:31,825,092...31,877,220
|
|
G |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of LFNG mRNA |
CTD |
PMID:29691375 |
|
NCBI chr12:14,030,551...14,038,996
Ensembl chr12:14,018,333...14,039,008
|
|
G |
Lipt2 |
lipoyl(octanoyl) transferase 2 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of LIPT2 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:154,504,563...154,506,890
Ensembl chr 1:154,504,563...154,506,890
|
|
G |
Lpl |
lipoprotein lipase |
increases response to substance multiple interactions |
ISO EXP |
LPL protein results in increased susceptibility to Potassium Chloride [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA |
CTD |
PMID:11786490 PMID:22228705 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP |
1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein]; [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein; AG 1879 inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein]; atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK1 protein]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein]; SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:18004999 PMID:18823320 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
multiple interactions |
ISO |
MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Potassium Chloride] |
CTD |
PMID:16949803 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK3 protein]; [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK3 protein; AG 1879 inhibits the reaction [Potassium Chloride results in increased phosphorylation of MAPK3 protein]; Atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of MAPK3 protein]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of MAPK3 protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of MAPK3 protein]; SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:18004999 PMID:18823320 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Potassium Chloride] |
CTD |
PMID:16949803 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions decreases phosphorylation |
EXP |
Okadaic Acid inhibits the reaction [Potassium Chloride results in decreased phosphorylation of MAPT protein] |
CTD |
PMID:9200503 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of MDH1 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
affects localization multiple interactions |
ISO |
Potassium Chloride affects the localization of MECP2 protein Potassium Chloride inhibits the reaction [MECP2 protein binds to BDNF promoter] |
CTD |
PMID:14593183 |
|
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
|
|
G |
Med7 |
mediator complex subunit 7 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of MED7 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr10:30,842,330...30,857,873
Ensembl chr10:30,842,292...30,859,220
|
|
G |
Mettl18 |
methyltransferase 18, RPL3 N3(tau)-histidine |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of METTL18 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr13:76,345,888...76,348,798
Ensembl chr13:76,345,957...76,348,836
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Potassium Chloride promotes the reaction [[MPO protein results in increased oxidation of dibromoacetonitrile] which results in increased chemical synthesis of Cyanides]; Potassium Chloride promotes the reaction [MPO protein results in increased oxidation of dibromoacetonitrile] |
CTD |
PMID:25614581 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions |
EXP |
[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased expression of MT1A protein; Spironolactone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased expression of MT1A protein] |
CTD |
PMID:17616752 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Myh4 |
myosin heavy chain 4 |
affects localization multiple interactions |
EXP |
Potassium Chloride affects the localization of MYH4 protein Ivermectin inhibits the reaction [Potassium Chloride affects the localization of MYH4 protein]; leptomycin B promotes the reaction [Potassium Chloride affects the localization of MYH4 protein] |
CTD |
PMID:29293066 |
|
NCBI chr10:51,923,149...51,946,297
Ensembl chr10:51,885,913...51,946,295
|
|
G |
Nherf2 |
NHERF family PDZ scaffold protein 2 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of NHERF2 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr10:13,662,461...13,672,975
Ensembl chr10:13,662,461...13,673,049
|
|
G |
Nos2 |
nitric oxide synthase 2 |
affects response to substance increases expression |
ISO EXP |
NOS2 protein affects the susceptibility to Potassium Chloride Potassium Chloride results in increased expression of NOS2 protein |
CTD |
PMID:11498454 PMID:27422357 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions decreases response to substance |
EXP ISO |
[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein; atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein] NOS3 protein results in decreased susceptibility to Potassium Chloride |
CTD |
PMID:15381055 PMID:18823320 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nptn |
neuroplastin |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of NPTN mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 8:58,996,873...59,063,402
Ensembl chr 8:58,996,887...59,063,401
|
|
G |
Npy |
neuropeptide Y |
increases expression |
EXP |
Potassium Chloride results in increased expression of NPY mRNA |
CTD |
PMID:2233698 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
EXP |
Potassium Chloride inhibits the reaction [Glucocorticoids binds to NR3C1 protein] |
CTD |
PMID:3015922 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases expression multiple interactions |
ISO |
Potassium Chloride results in increased expression of NR4A1 mRNA Dronabinol inhibits the reaction [Potassium Chloride results in increased expression of NR4A1 mRNA] |
CTD |
PMID:29691375 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases expression |
EXP |
Potassium Chloride results in increased expression of NR4A2 mRNA |
CTD |
PMID:8737662 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
EXP |
Potassium Chloride results in increased expression of NRF1 mRNA; Potassium Chloride results in increased expression of NRF1 protein |
CTD |
PMID:20438809 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Nrxn2 |
neurexin 2 |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of NRXN2 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297
|
|
G |
Nrxn3 |
neurexin 3 |
increases expression |
EXP |
Potassium Chloride results in increased expression of NRXN3 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 6:107,641,760...109,272,849
Ensembl chr 6:107,641,780...109,272,044
|
|
G |
Pars2 |
prolyl-tRNA synthetase 2, mitochondrial |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of PARS2 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:121,433,993...121,439,158
Ensembl chr 5:121,434,096...121,439,154
|
|
G |
Pgr |
progesterone receptor |
increases activity |
ISO |
Potassium Chloride results in increased activity of PGR protein |
CTD |
PMID:9879984 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
affects response to substance |
ISO |
PKD1 protein affects the susceptibility to Potassium Chloride |
CTD |
PMID:18679710 |
|
NCBI chr10:13,573,779...13,621,138
Ensembl chr10:13,573,021...13,621,128
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
EXP |
PLD2 protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA]; PLD2 protein affects the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of CREB1 protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of MAPK1 protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of MAPK3 protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein] |
CTD |
PMID:18004999 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
EXP |
Potassium Chloride results in increased expression of PPARGC1A mRNA; Potassium Chloride results in increased expression of PPARGC1A protein |
CTD |
PMID:20438809 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
multiple interactions |
EXP |
[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of PPP1R12A protein; atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in increased phosphorylation of PPP1R12A protein] |
CTD |
PMID:18823320 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
EXP |
Potassium Chloride results in increased expression of PTGS2 protein |
CTD |
PMID:27422357 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
multiple interactions increases phosphorylation |
EXP |
1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein]; CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein]; PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein] |
CTD |
PMID:18004999 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of RAPGEF4 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rassf1 |
Ras association domain family member 1 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of RASSF1 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
|
|
G |
Rassf10 |
Ras association domain family member 10 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of RASSF10 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:167,058,277...167,063,591
Ensembl chr 1:167,058,099...167,063,572
|
|
G |
Rcvrn |
recoverin |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of RCVRN mRNA |
CTD |
PMID:29691375 |
|
NCBI chr10:52,388,706...52,396,454
Ensembl chr10:52,388,706...52,396,453
|
|
G |
Rho |
rhodopsin |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of RHO mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 4:148,975,597...148,988,693
Ensembl chr 4:148,980,611...148,985,773
|
|
G |
Rit1 |
Ras-like without CAAX 1 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of RIT1 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:174,180,848...174,195,455
|
|
G |
Rragc |
Ras-related GTP binding C |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of RRAGC mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
|
|
G |
Scg2 |
secretogranin II |
increases expression |
EXP |
Potassium Chloride results in increased expression of SCG2 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
multiple interactions |
ISO |
SCN10A protein affects the reaction [Potassium Chloride results in increased secretion of TAC1 protein alternative form] |
CTD |
PMID:18845912 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Sct |
secretin |
multiple interactions increases secretion |
EXP |
Cadmium inhibits the reaction [Potassium Chloride results in increased secretion of SCT protein]; Nicardipine inhibits the reaction [Potassium Chloride results in increased secretion of SCT protein]; omega-Agatoxin IVA inhibits the reaction [Potassium Chloride results in increased secretion of SCT protein]; omega-Conotoxin GVIA inhibits the reaction [Potassium Chloride results in increased secretion of SCT protein]; Tetrodotoxin inhibits the reaction [Potassium Chloride results in increased secretion of SCT protein] |
CTD |
PMID:15963647 PMID:16888165 |
|
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
|
|
G |
Senp8 |
SUMO peptidase family member, NEDD8 specific |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of SENP8 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:60,135,446...60,148,836
Ensembl chr 8:60,121,714...60,148,928
|
|
G |
Serpine1 |
serpin family E member 1 |
increases secretion |
EXP |
Potassium Chloride results in increased secretion of SERPINE1 protein |
CTD |
PMID:21596853 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Setd7 |
SET domain containing 7, histone lysine methyltransferase |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of SETD7 mRNA |
CTD |
PMID:20211609 |
|
NCBI chr 2:135,562,683...135,605,468
Ensembl chr 2:135,562,683...135,605,468
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of SFPQ mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
|
|
G |
Sin3a |
SIN3 transcription regulator family member A |
multiple interactions |
ISO |
Potassium Chloride inhibits the reaction [SIN3A protein binds to BDNF promoter] |
CTD |
PMID:14593183 |
|
NCBI chr 8:57,481,539...57,536,195
Ensembl chr 8:57,481,573...57,536,192
|
|
G |
Slc12a5 |
solute carrier family 12 member 5 |
increases expression |
EXP |
Potassium Chloride results in increased expression of SLC12A5 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 3:153,696,517...153,735,801
Ensembl chr 3:153,696,517...153,735,765
|
|
G |
Slc26a5 |
solute carrier family 26 member 5 |
increases expression decreases expression |
EXP |
Potassium Chloride results in increased expression of SLC26A5 mRNA Potassium Chloride results in decreased expression of SLC26A5 mRNA |
CTD |
PMID:21624428 |
|
NCBI chr 4:13,210,260...13,249,289
Ensembl chr 4:13,210,260...13,249,289
|
|
G |
Slc2a9 |
solute carrier family 2 member 9 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of SLC2A9 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981
|
|
G |
Slc30a8 |
solute carrier family 30 member 8 |
multiple interactions |
EXP |
SLC30A8 protein affects the reaction [Potassium Chloride results in increased secretion of INS1 protein] |
CTD |
PMID:19479076 |
|
NCBI chr 7:83,591,993...83,627,786
Ensembl chr 7:83,591,993...83,626,305
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of SLC38A2 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
|
|
G |
Smim5 |
small integral membrane protein 5 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of SMIM5 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813
|
|
G |
Snap25 |
synaptosome associated protein 25 |
affects splicing |
EXP |
Potassium Chloride affects the splicing of SNAP25 exon |
CTD |
PMID:22684629 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions increases secretion |
EXP ISO |
[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in decreased activity of SOD1 protein; [Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased activity of SOD1 protein; Spironolactone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in decreased activity of SOD1 protein]; Spironolactone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased activity of SOD1 protein] Egtazic Acid inhibits the reaction [Potassium Chloride results in increased secretion of SOD1 protein] |
CTD |
PMID:17616752 PMID:28085149 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions increases phosphorylation |
EXP |
CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of SRC protein]; SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of CREB1 protein]; SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; SRC protein affects the reaction [Potassium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:18004999 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Syn1 |
synapsin I |
multiple interactions increases expression |
EXP |
1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; KN 62 inhibits the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; PLD2 protein affects the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; U 0126 inhibits the reaction [Potassium Chloride results in increased expression of SYN1 mRNA]; U 0126 inhibits the reaction [Potassium Chloride results in increased expression of SYN1 protein] Potassium Chloride results in increased expression of SYN1 mRNA; Potassium Chloride results in increased expression of SYN1 protein |
CTD |
PMID:18004999 |
|
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
|
|
G |
Syt5 |
synaptotagmin 5 |
increases expression |
EXP |
Potassium Chloride results in increased expression of SYT5 mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067
|
|
G |
Tac1 |
tachykinin, precursor 1 |
increases secretion multiple interactions increases expression |
ISO EXP |
Potassium Chloride results in increased secretion of TAC1 protein alternative form SCN10A protein affects the reaction [Potassium Chloride results in increased secretion of TAC1 protein alternative form] 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; 2-aminoethyl diphenylborinate inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]; 2-aminoethyl diphenylborinate promotes the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA; [KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein; Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; icatibant inhibits the reaction [KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]]; Iloprost promotes the reaction [Potassium Chloride results in increased secretion of TAC1 protein]; KNG1 protein inhibits the reaction [Potassium Chloride results in increased secretion of TAC1 protein]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased expression of TAC1 mRNA]; nimesulide inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with Potassium Chloride] results in increased secretion of TAC1 protein] Potassium Chloride results in increased expression of TAC1 mRNA |
CTD |
PMID:16039053 PMID:16696851 PMID:18845912 PMID:21294877 PMID:21811393 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tex10 |
testis expressed 10 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of TEX10 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:62,762,230...62,808,373
Ensembl chr 5:62,762,230...62,808,373
|
|
G |
Tfam |
transcription factor A, mitochondrial |
increases expression |
EXP |
Potassium Chloride results in increased expression of TFAM mRNA |
CTD |
PMID:20438809 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tgds |
TDP-glucose 4,6-dehydratase |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of TGDS mRNA |
CTD |
PMID:29691375 |
|
NCBI chr15:95,175,064...95,195,555
Ensembl chr15:95,174,608...95,195,554
|
|
G |
Tgif1 |
TGFB-induced factor homeobox 1 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of TGIF1 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
|
|
G |
Thap6 |
THAP domain containing 6 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of THAP6 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr14:16,092,919...16,113,528
Ensembl chr14:16,101,312...16,113,448
|
|
G |
Tlcd5 |
TLC domain containing 5 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of TMEM136 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:43,481,388...43,486,288
Ensembl chr 8:43,479,016...43,486,290
|
|
G |
Tmem177 |
transmembrane protein 177 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of TMEM177 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
EXP |
Potassium Chloride results in increased expression of TNF protein |
CTD |
PMID:27422357 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of TP53 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpm1 |
tropomyosin 1 |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of TPM1 mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
multiple interactions increases activity |
EXP |
capsazepine inhibits the reaction [Potassium Chloride results in increased activity of TRPM8 protein]; icilin inhibits the reaction [Potassium Chloride results in increased activity of TRPM8 protein]; Menthol inhibits the reaction [Potassium Chloride results in increased activity of TRPM8 protein]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [Potassium Chloride results in increased activity of TRPM8 protein]; Phenanthrolines inhibits the reaction [Potassium Chloride results in increased activity of TRPM8 protein] |
CTD |
PMID:19363131 |
|
NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552
|
|
G |
Umod |
uromodulin |
multiple interactions |
EXP |
[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of UMOD mRNA |
CTD |
PMID:22228705 |
|
NCBI chr 1:173,816,341...173,829,681
Ensembl chr 1:173,816,339...173,830,302
|
|
G |
Unc13c |
unc-13 homolog C |
decreases expression |
EXP |
Potassium Chloride results in decreased expression of UNC13C mRNA |
CTD |
PMID:16412482 |
|
NCBI chr 8:74,247,026...74,697,629
Ensembl chr 8:74,247,899...74,673,223
|
|
G |
Wdr5b |
WD repeat domain 5B |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of WDR5B mRNA |
CTD |
PMID:29691375 |
|
NCBI chr11:64,710,945...64,712,804
Ensembl chr11:64,710,355...64,712,807
|
|
G |
Yy1 |
YY1 transcription factor |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of YY1 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
|
|
G |
Zc3h10 |
zinc finger CCCH type containing 10 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZC3H10 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 7:973,415...977,742
Ensembl chr 7:972,855...979,349
|
|
G |
Zcchc9 |
zinc finger CCHC-type containing 9 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZCCHC9 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 2:23,038,156...23,048,249
Ensembl chr 2:23,038,317...23,048,217
|
|
G |
Zfp287 |
zinc finger protein 287 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF287 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr10:47,395,650...47,415,610
Ensembl chr10:47,397,285...47,439,755
|
|
G |
Zfp397 |
zinc finger protein 397 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF397 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr18:15,241,764...15,253,148
Ensembl chr18:15,242,096...15,300,984
|
|
G |
Zfp574 |
zinc finger protein 574 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of ZNF574 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:80,667,984...80,678,257
Ensembl chr 1:80,664,259...80,679,427
|
|
G |
Zfp606 |
zinc finger protein 606 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF606 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 1:72,981,920...73,022,423
Ensembl chr 1:72,981,989...73,008,072
|
|
G |
Zfp691 |
zinc finger protein 691 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF691 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 5:132,780,259...132,784,954
Ensembl chr 5:132,780,181...132,785,000
|
|
G |
Zfp7 |
zinc finger protein 7 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF7 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 7:108,598,666...108,615,740
Ensembl chr 7:108,607,689...108,618,185
|
|
G |
Zkscan7 |
zinc finger with KRAB and SCAN domains 7 |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZKSCAN7 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 8:122,501,938...122,519,600
Ensembl chr 8:122,502,218...122,519,600
|
|
G |
Znf624l |
zinc finger protein 624 like |
multiple interactions |
ISO |
[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF624 mRNA |
CTD |
PMID:29691375 |
|
NCBI chr 7:7,853,363...7,890,995
Ensembl chr 7:7,853,403...7,890,974
|
|